Interim analysis of a 3-year follow-up study of NS5A and NS3 resistance-associated substitutions after treatment with grazoprevir-containing regimens in participants with chronic HCV infection
Keyword(s):
Keyword(s):
2017 ◽
Vol 2017
◽
pp. 1-8
Keyword(s):
2016 ◽
Vol 64
(2)
◽
pp. S612-S613
◽
Keyword(s):
2010 ◽
Vol 11
(4)
◽
pp. 197-201
◽
Keyword(s):
Keyword(s):